{"hands_on_practices": [{"introduction": "Accurate diagnosis is the critical first step in managing gestational diabetes mellitus (GDM), directly influencing maternal and fetal outcomes. This exercise hones your ability to apply the one-step diagnostic strategy using a $75$-g Oral Glucose Tolerance Test (OGTT), as endorsed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG). Mastering the interpretation of these results against specific thresholds is fundamental to confidently identifying GDM in clinical practice. [@problem_id:4445435]", "problem": "A patient at $26$ weeks of gestation undergoes a one-step $75$-$\\mathrm{g}$ Oral Glucose Tolerance Test (OGTT) in a clinic that follows the International Association of Diabetes and Pregnancy Study Groups (IADPSG) and World Health Organization (WHO) diagnostic framework for Gestational Diabetes Mellitus (GDM). Plasma glucose values are: fasting $94\\,\\mathrm{mg/dL}$, $1$-hour $182\\,\\mathrm{mg/dL}$, and $2$-hour $151\\,\\mathrm{mg/dL}$. Based on the risk-derived thresholds endorsed by IADPSG/WHO and the rule for diagnosis, determine whether GDM is diagnosed and specify which time-point thresholds were exceeded.\n\nChoose the single best option:\n\nA. GDM is diagnosed; the fasting and $1$-hour thresholds are exceeded; the $2$-hour value is below its threshold.\n\nB. GDM is diagnosed; only the $1$-hour threshold is exceeded; fasting and $2$-hour values are below their thresholds.\n\nC. GDM is not diagnosed because at least two abnormal values are required on a $75$-$\\mathrm{g}$ OGTT.\n\nD. GDM is diagnosed; the $1$-hour and $2$-hour thresholds are exceeded; the fasting value is below its threshold.\n\nE. GDM is not diagnosed; none of the values exceed the thresholds for the $75$-$\\mathrm{g}$ OGTT; the $2$-hour threshold is $140\\,\\mathrm{mg/dL}$.", "solution": "The problem statement is first validated to ensure it is scientifically sound, well-posed, and objective.\n\n**Step 1: Extract Givens**\n- Patient gestational age: $26$ weeks\n- Test administered: one-step $75$-$\\mathrm{g}$ Oral Glucose Tolerance Test (OGTT)\n- Diagnostic framework: International Association of Diabetes and Pregnancy Study Groups (IADPSG) and World Health Organization (WHO)\n- Plasma glucose measurements:\n    - Fasting: $94\\,\\mathrm{mg/dL}$\n    - $1$-hour post-load: $182\\,\\mathrm{mg/dL}$\n    - $2$-hour post-load: $151\\,\\mathrm{mg/dL}$\n- Question: Determine if Gestational Diabetes Mellitus (GDM) is diagnosed and identify which diagnostic thresholds were exceeded.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding:** The problem is based on established, internationally recognized clinical guidelines for the diagnosis of GDM. The IADPSG/WHO criteria for the $75$-$\\mathrm{g}$ OGTT are a standard in modern obstetrics. The given glucose values are physiologically realistic for a patient being tested for GDM. The problem is scientifically and factually sound.\n- **Well-Posedness:** The problem provides a complete set of patient data and specifies the exact diagnostic criteria to be applied. The question is unambiguous, leading to a single, verifiable conclusion. The problem is well-posed.\n- **Objectivity:** The problem statement is composed of objective, quantitative data and references a specific, formal diagnostic protocol. It is free from subjective or ambiguous language.\n\n**Step 3: Verdict and Action**\nThe problem is valid. It is a straightforward application of a defined diagnostic algorithm based on numerical data. The solution will proceed by applying the specified IADPSG/WHO criteria to the patient's test results.\n\n**Derivation of Solution**\n\nThe core principle for diagnosing Gestational Diabetes Mellitus (GDM) according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) and the World Health Organization (WHO) using a one-step $75$-$\\mathrm{g}$ Oral Glucose Tolerance Test (OGTT) is that the diagnosis is made if **any one or more** of the following plasma glucose thresholds are met or exceeded:\n- Fasting: $\\geq 92\\,\\mathrm{mg/dL}$\n- $1$-hour: $\\geq 180\\,\\mathrm{mg/dL}$\n- $2$-hour: $\\geq 153\\,\\mathrm{mg/dL}$\n\nThe patient's results are compared against these thresholds:\n1.  **Fasting glucose:** The patient's value is $94\\,\\mathrm{mg/dL}$. The threshold is $92\\,\\mathrm{mg/dL}$. Since $94\\,\\mathrm{mg/dL} \\geq 92\\,\\mathrm{mg/dL}$, this criterion is met.\n2.  **$1$-hour glucose:** The patient's value is $182\\,\\mathrm{mg/dL}$. The threshold is $180\\,\\mathrm{mg/dL}$. Since $182\\,\\mathrm{mg/dL} \\geq 180\\,\\mathrm{mg/dL}$, this criterion is also met.\n3.  **$2$-hour glucose:** The patient's value is $151\\,\\mathrm{mg/dL}$. The threshold is $153\\,\\mathrm{mg/dL}$. Since $151\\,\\mathrm{mg/dL} < 153\\,\\mathrm{mg/dL}$, this criterion is not met.\n\nAccording to the IADPSG/WHO rule, meeting even one of these criteria is sufficient for a diagnosis of GDM. In this case, the patient has met two criteria (fasting and $1$-hour). Therefore, a diagnosis of GDM is confirmed.\n\n**Evaluation of Options**\n\nA. GDM is diagnosed; the fasting and $1$-hour thresholds are exceeded; the $2$-hour value is below its threshold.\n- This statement accurately reflects the analysis. GDM is diagnosed because two values exceeded their respective thresholds. The fasting value ($94\\,\\mathrm{mg/dL}$) exceeded the $92\\,\\mathrm{mg/dL}$ threshold. The $1$-hour value ($182\\,\\mathrm{mg/dL}$) exceeded the $180\\,\\mathrm{mg/dL}$ threshold. The $2$-hour value ($151\\,\\mathrm{mg/dL}$) was below the $153\\,\\mathrm{mg/dL}$ threshold.\n- Verdict: **Correct**.\n\nB. GDM is diagnosed; only the $1$-hour threshold is exceeded; fasting and $2$-hour values are below their thresholds.\n- This statement is factually incorrect. It claims the fasting value is below its threshold, but $94\\,\\mathrm{mg/dL}$ is greater than or equal to the threshold of $92\\,\\mathrm{mg/dL}$.\n- Verdict: **Incorrect**.\n\nC. GDM is not diagnosed because at least two abnormal values are required on a $75$-$\\mathrm{g}$ OGTT.\n- This statement is incorrect on two counts. First, GDM is diagnosed. Second, the reasoning is flawed. The \"at least two abnormal values\" rule applies to the older two-step approach, typically using a $100$-$\\mathrm{g}$ OGTT and Carpenter-Coustan criteria. The IADPSG/WHO one-step $75$-$\\mathrm{g}$ OGTT diagnostic rule requires only one or more abnormal values.\n- Verdict: **Incorrect**.\n\nD. GDM is diagnosed; the $1$-hour and $2$-hour thresholds are exceeded; the fasting value is below its threshold.\n- This statement contains multiple factual errors. The $2$-hour threshold was not exceeded ($151\\,\\mathrm{mg/dL} < 153\\,\\mathrm{mg/dL}$), and the fasting value was not below its threshold ($94\\,\\mathrm{mg/dL} \\geq 92\\,\\mathrm{mg/dL}$).\n- Verdict: **Incorrect**.\n\nE. GDM is not diagnosed; none of the values exceed the thresholds for the $75$-$\\mathrm{g}$ OGTT; the $2$-hour threshold is $140\\,\\mathrm{mg/dL}$.\n- This statement is incorrect. GDM is diagnosed. Two values exceeded their thresholds. Furthermore, it incorrectly states the $2$-hour threshold as $140\\,\\mathrm{mg/dL}$; for the IADPSG criteria, it is $153\\,\\mathrm{mg/dL}$.\n- Verdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "4445435"}, {"introduction": "Once GDM is diagnosed, the initial management focuses on lifestyle modifications. This practice simulates the pivotal decision-making process that follows: evaluating the efficacy of diet and exercise through self-monitored blood glucose (SMBG) logs. By analyzing a week of glycemic data, you will practice applying established targets to determine if and when pharmacotherapy is warranted, a core competency in GDM management. [@problem_id:4445340]", "problem": "A pregnant patient with Gestational Diabetes Mellitus (GDM) at $30$ weeks of gestation has completed $1$ week of medical nutrition therapy and moderate-intensity physical activity, and brings capillary glucose logs measured by a calibrated home glucometer. She checks fasting each morning and $1$-hour postprandial after each main meal.\n\nFasting values (morning, days $1$–$7$): $92$, $96$, $94$, $97$, $100$, $105$, $93$ mg/dL.\n\nOne-hour postprandial values by day (breakfast, lunch, dinner):\n- Day $1$: $142$, $148$, $135$ mg/dL\n- Day $2$: $150$, $138$, $145$ mg/dL\n- Day $3$: $155$, $144$, $139$ mg/dL\n- Day $4$: $141$, $152$, $147$ mg/dL\n- Day $5$: $135$, $149$, $153$ mg/dL\n- Day $6$: $137$, $146$, $151$ mg/dL\n- Day $7$: $143$, $136$, $150$ mg/dL\n\nBased on widely accepted glycemic targets for Gestational Diabetes Mellitus (GDM) and standard criteria used to initiate pharmacotherapy after lifestyle intervention, which of the following is the best next step, and what specific metric most directly supports the decision?\n\nA. Continue nutrition and activity counseling without pharmacotherapy; decision guided by acceptable weekly mean glucose values overall.\n\nB. Initiate pharmacotherapy; the decision is driven by the proportion of $1$-hour postprandial values exceeding the target threshold on more than $30\\%$ of measurements.\n\nC. Initiate pharmacotherapy solely because the highest observed $1$-hour postprandial value exceeded $150$ mg/dL; decision driven by the single peak value.\n\nD. Defer treatment changes and obtain Hemoglobin A1c (HbA1c) to guide whether to initiate pharmacotherapy now.\n\nE. Initiate pharmacotherapy; the decision is driven by the average fasting glucose exceeding the threshold, despite most postprandials being near target.", "solution": "The problem statement is evaluated as valid. It presents a realistic clinical scenario in obstetrics and gynecology concerning the management of Gestational Diabetes Mellitus (GDM). The provided data are internally consistent, scientifically plausible, and sufficient to arrive at a logical clinical decision based on established medical guidelines. The problem is well-posed and objective.\n\nThe core of this problem is the application of standard clinical guidelines for GDM management to a patient's self-monitored blood glucose data. The decision to initiate pharmacotherapy after a trial of lifestyle modification (medical nutrition therapy and physical activity) is based on whether glycemic targets are met.\n\nFirst, we must establish the widely accepted glycemic targets for GDM, as referenced in the problem statement. According to the American College of Obstetricians and Gynecologists (ACOG), these targets are:\n- Fasting glucose: $\\leq 95$ mg/dL\n- One-hour postprandial glucose: $\\leq 140$ mg/dL\n- Two-hour postprandial glucose: $\\leq 120$ mg/dL\n\nThe patient is monitoring fasting and $1$-hour postprandial values, so the relevant targets are $\\leq 95$ mg/dL and $\\leq 140$ mg/dL, respectively. Pharmacotherapy is typically indicated if a significant proportion of glucose values (often considered to be $\\geq 30\\%$ to $\\geq 50\\%$) remain above these targets after a $1$ to $2$-week trial of lifestyle changes.\n\nNext, we analyze the patient's glucose logs over the $7$-day period.\n\n1.  **Analysis of Fasting Glucose Values:**\n    - Data: $92$, $96$, $94$, $97$, $100$, $105$, $93$ mg/dL.\n    - Target: $\\leq 95$ mg/dL.\n    - Values exceeding the target: $96$, $97$, $100$, $105$ mg/dL.\n    - There are $4$ out of $7$ fasting values above the target.\n    - The proportion of elevated fasting values is $4/7 \\approx 0.571$, or $57.1\\%$.\n    - The average fasting glucose is $\\frac{92+96+94+97+100+105+93}{7} = \\frac{677}{7} \\approx 96.7$ mg/dL.\n    - Conclusion: The patient's fasting glucose levels are not adequately controlled, with both the average value and the proportion of elevated readings exceeding the target.\n\n2.  **Analysis of One-Hour Postprandial Glucose Values:**\n    - Data: There are $3$ measurements per day for $7$ days, for a total of $21$ measurements.\n    - Target: $\\leq 140$ mg/dL.\n    - Values exceeding the target are:\n        - Day $1$: $142$, $148$\n        - Day $2$: $150$, $145$\n        - Day $3$: $155$, $144$\n        - Day $4$: $141$, $152$, $147$\n        - Day $5$: $149$, $153$\n        - Day $6$: $146$, $151$\n        - Day $7$: $143$, $150$\n    - Counting these values, we find there are $15$ measurements exceeding the $140$ mg/dL target.\n    - The proportion of elevated $1$-hour postprandial values is $15/21 = 5/7 \\approx 0.714$, or $71.4\\%$.\n    - Conclusion: The patient's postprandial glucose levels are also not adequately controlled, with a very high percentage of readings above the target.\n\n**Overall Clinical Decision:**\nThe patient has failed the trial of medical nutrition therapy and physical activity, as demonstrated by a significant number of both fasting ($57.1\\%$) and postprandial ($71.4\\%$) glucose values being above the established targets. Therefore, the appropriate next step is to initiate pharmacotherapy (e.g., insulin or metformin).\n\nNow, we evaluate each option:\n\n**A. Continue nutrition and activity counseling without pharmacotherapy; decision guided by acceptable weekly mean glucose values overall.**\n- The recommendation to continue without pharmacotherapy is incorrect. The data clearly shows that glycemic targets are not being met. Both fasting and postprandial glucose levels are poorly controlled. Relying on an \"overall\" mean can be misleading and is not standard practice; decisions are based on patterns and proportions of values relative to specific fasting and postprandial thresholds.\n- **Verdict: Incorrect.**\n\n**B. Initiate pharmacotherapy; the decision is driven by the proportion of $1$-hour postprandial values exceeding the target threshold on more than $30\\%$ of measurements.**\n- The recommendation to \"initiate pharmacotherapy\" is correct.\n- The supporting metric is factually accurate based on our analysis. The proportion of high postprandial values is $71.4\\%$, which is substantially more than the clinical threshold of $30\\%$. This high rate of postprandial hyperglycemia is a sufficient and standard reason to start medication.\n- **Verdict: Correct.**\n\n**C. Initiate pharmacotherapy solely because the highest observed $1$-hour postprandial value exceeded $150$ mg/dL; decision driven by the single peak value.**\n- While the action to \"initiate pharmacotherapy\" is correct, the reasoning is clinically unsound. Management decisions for GDM are based on trends and patterns over time ($1$-$2$ weeks of data), not on a single extreme reading. Basing treatment on one value could lead to overtreatment and hypoglycemia.\n- **Verdict: Incorrect.**\n\n**D. Defer treatment changes and obtain Hemoglobin A1c (HbA1c) to guide whether to initiate pharmacotherapy now.**\n- This is an incorrect course of action. Hemoglobin A1c reflects average glycemia over the preceding $2$-$3$ months. It is not sensitive enough for the weekly or bi-weekly adjustments needed for GDM management, where rapid fetal growth necessitates tight, real-time control. The current capillary glucose data are sufficient and indicate an immediate need for intervention. Deferring treatment would be inappropriate.\n- **Verdict: Incorrect.**\n\n**E. Initiate pharmacotherapy; the decision is driven by the average fasting glucose exceeding the threshold, despite most postprandials being near target.**\n- The recommendation to \"initiate pharmacotherapy\" is correct, and the observation that the average fasting glucose exceeds the threshold ($\\approx 96.7$ mg/dL vs. a target of $\\leq 95$ mg/dL) is also correct. However, the clause \"despite most postprandials being near target\" is factually false. As calculated, $71.4\\%$ of postprandial values were *above* target. This contradictory and incorrect statement invalidates the entire rationale.\n- **Verdict: Incorrect.**\n\nBased on the analysis, Option B provides the correct clinical action supported by a factually accurate and clinically sufficient reason based on the provided data and standard guidelines. While the poor fasting control is also a strong reason, the justification provided in Option B is entirely valid and stands on its own.", "answer": "$$\\boxed{B}$$", "id": "4445340"}, {"introduction": "When lifestyle interventions are insufficient to control hyperglycemia, initiating insulin therapy becomes necessary. This exercise provides hands-on practice in a fundamental clinical calculation: determining a patient's initial total daily insulin dose based on their weight and physiological state in late pregnancy. You will apply principles of basal-bolus therapy to partition this dose, translating clinical guidelines into a quantitative, patient-specific starting regimen. [@problem_id:4445412]", "problem": "A pregnant patient with Gestational Diabetes Mellitus (GDM) in the third trimester has a measured body weight of $80\\,\\mathrm{kg}$. Late gestation is characterized by increased insulin resistance driven by placental hormones, necessitating higher initial insulin requirements than earlier in pregnancy. A well-tested clinical approach for an initial estimate in late gestation uses a weight-based factor of $0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$ to compute the total daily insulin dose. The physiologic rationale for a basal-bolus regimen is to partition insulin into a basal component that suppresses hepatic glucose production and a prandial component that targets postprandial glucose excursions. In late gestation, it is reasonable to allocate a greater fraction of the total daily dose to prandial insulin due to accentuated postprandial hyperglycemia from insulin resistance.\n\nStarting from these principles, derive the initial total daily insulin dose $D$ from the patient’s weight, select a physiologically justified basal fraction $\\beta$ and prandial fraction $\\gamma$ that sum to $1$ with $\\gamma>\\beta$, and distribute the prandial dose equally across three meals. Compute:\n- the total daily dose $D$ in $\\mathrm{U/day}$,\n- the basal daily dose $B$ in $\\mathrm{U/day}$,\n- the total prandial daily dose $P$ in $\\mathrm{U/day}$,\n- and the three equal per-meal prandial doses $p_1$, $p_2$, $p_3$ in $\\mathrm{U}$ per meal.\n\nRound each computed dose to two significant figures. Express all insulin quantities in international units (U). Provide your final numeric outputs in the order $D$, $B$, $P$, $p_1$, $p_2$, $p_3$ as a single row matrix without units.", "solution": "The problem is first validated against the established criteria.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- Patient's body weight, $W$: $80\\,\\mathrm{kg}$\n- Patient condition: Pregnant with Gestational Diabetes Mellitus (GDM) in the third trimester.\n- Initial insulin requirement estimation factor, $f$: $0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$\n- Insulin regimen type: Basal-bolus\n- Basal fraction of total daily dose: $\\beta$\n- Prandial fraction of total daily dose: $\\gamma$\n- Constraints on fractions: $\\beta + \\gamma = 1$ and $\\gamma > \\beta$.\n- Prandial dose distribution: equally across three meals.\n- Required outputs: Total daily dose $D$, basal daily dose $B$, total prandial daily dose $P$, and per-meal prandial doses $p_1$, $p_2$, $p_3$.\n- Rounding requirement: Round each computed dose to two significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding**: The problem is based on established clinical principles for managing GDM with insulin. The weight-based dosing factor of $0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$ is a clinically appropriate value for initial insulin estimation in late-term pregnancy. The description of a basal-bolus regimen, including the distinct roles of basal and prandial insulin, is factually correct. The stated rationale for allocating a larger fraction of the total dose to prandial insulin ($\\gamma > \\beta$) due to accentuated postprandial hyperglycemia from insulin resistance in late gestation is a standard, physiologically sound clinical strategy. The problem is scientifically grounded.\n- **Well-Posed**: The problem requires the selection of a basal fraction $\\beta$ and prandial fraction $\\gamma$ that meet specified criteria. While a specific value is not given, the problem provides sufficient clinical context (\"accentuated postprandial hyperglycemia\") and mathematical constraints ($\\beta + \\gamma = 1$, $\\gamma > \\beta$) to guide a reasoned, standard choice. A common clinical starting point that satisfies these conditions is a $40\\%/60\\%$ split ($40\\%$ basal, $60\\%$ prandial), making $\\beta=0.4$ and $\\gamma=0.6$. By selecting this standard, justifiable split, the problem becomes well-posed, with a unique solution following from the choice. All other necessary data for subsequent calculations are provided.\n- **Objective and Consistent**: The problem uses clear, precise, and objective language. It is self-contained and free of internal contradictions.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid**. It represents a standard clinical calculation problem that requires applying given principles and making a justified choice based on the provided context. The solution process may proceed.\n\n### Solution\n\nThe solution is derived by systematically applying the principles and data provided in the problem statement.\n\n1.  **Computation of the Total Daily Insulin Dose ($D$)**\n    The total daily insulin dose, $D$, is determined by multiplying the patient's body weight, $W$, by the specified weight-based dosing factor, $f$.\n    Given:\n    - Weight $W = 80\\,\\mathrm{kg}$\n    - Dosing factor $f = 0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$\n\n    The total daily dose is:\n    $$D = W \\times f = 80\\,\\mathrm{kg} \\times 0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}} = 72\\,\\mathrm{U\\,day^{-1}}$$\n    To two significant figures, $D$ is $72\\,\\mathrm{U}$.\n\n2.  **Selection of Basal and Prandial Fractions ($\\beta$, $\\gamma$)**\n    The problem requires partitioning the total daily dose into a basal component and a prandial component, with fractions $\\beta$ and $\\gamma$ respectively. The constraints are $\\beta + \\gamma = 1$ and $\\gamma > \\beta$. The clinical context notes \"accentuated postprandial hyperglycemia,\" justifying a larger prandial fraction. A standard, physiologically justified starting point that satisfies these conditions is to allocate $40\\%$ of the total dose as basal insulin and $60\\%$ as prandial insulin.\n    Therefore, we select:\n    - Basal fraction: $\\beta = 0.4$\n    - Prandial fraction: $\\gamma = 0.6$\n    These values satisfy the given constraints: $0.4 + 0.6 = 1$ and $0.6 > 0.4$.\n\n3.  **Computation of the Basal Daily Dose ($B$)**\n    The basal dose, $B$, is the fraction $\\beta$ of the total daily dose $D$.\n    $$B = \\beta \\times D = 0.4 \\times 72\\,\\mathrm{U} = 28.8\\,\\mathrm{U}$$\n    Rounding this result to two significant figures yields:\n    $$B \\approx 29\\,\\mathrm{U}$$\n\n4.  **Computation of the Total Prandial Daily Dose ($P$)**\n    The total prandial dose, $P$, is the fraction $\\gamma$ of the total daily dose $D$.\n    $$P = \\gamma \\times D = 0.6 \\times 72\\,\\mathrm{U} = 43.2\\,\\mathrm{U}$$\n    Rounding this result to two significant figures yields:\n    $$P \\approx 43\\,\\mathrm{U}$$\n    A consistency check using the rounded values shows $B + P = 29\\,\\mathrm{U} + 43\\,\\mathrm{U} = 72\\,\\mathrm{U}$, which matches the rounded total daily dose $D$.\n\n5.  **Computation of the Per-Meal Prandial Doses ($p_1, p_2, p_3$)**\n    The total prandial dose $P$ is distributed equally among three meals.\n    $$p_1 = p_2 = p_3 = \\frac{P}{3}$$\n    Using the unrounded value of $P$ for calculation:\n    $$p_1 = p_2 = p_3 = \\frac{43.2\\,\\mathrm{U}}{3} = 14.4\\,\\mathrm{U}$$\n    Rounding this result to two significant figures yields:\n    $$p_1 = p_2 = p_3 \\approx 14\\,\\mathrm{U}$$\n\n6.  **Final Values**\n    The computed and rounded values for the required outputs are:\n    - Total daily dose $D = 72\\,\\mathrm{U}$\n    - Basal daily dose $B = 29\\,\\mathrm{U}$\n    - Total prandial daily dose $P = 43\\,\\mathrm{U}$\n    - Per-meal prandial dose $p_1 = p_2 = p_3 = 14\\,\\mathrm{U}$\n\nThese values will be presented in the specified matrix format.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n72 & 29 & 43 & 14 & 14 & 14\n\\end{pmatrix}\n}\n$$", "id": "4445412"}]}